Health·2,833 stories
Research from the University of Texas at San Antonio links a dramatic surge in U.S. poison control calls about semaglutide (Ozempic and Wegovy) to the drug's 2021 FDA approval for weight management, w
Weill Cornell researchers engineered ultrasmall silica nanoparticles that selectively killed aggressive prostate cancer cells and reactivated the immune system in mice, producing complete remissions w
University of Warwick researchers have decoded how bacterial enzymes cooperate to produce multiple variants of powerful anti-cancer drugs, identifying molecular 'docking domains' as the connectors beh
A major Australian trial has found the MenB vaccine offers no protection against gonorrhoea in men, undermining earlier studies that had prompted the NHS to begin offering the jab to gay and bisexual
Governor Maura Healey summoned Mass General Brigham and its striking nurses to the State House for a late-afternoon meeting aimed at ending the largest nurses strike in Massachusetts history, the firs
A drug that softens aging ovaries more than doubled conception rates and quintupled litter sizes in older rats and mice in a study led by Chinese researchers, raising hopes that a similar intervention
Trump administration officials, including Secretary of State Marco Rubio and HHS Secretary Robert F. Kennedy Jr., met privately with pharmaceutical leaders to push for bringing production of 86 essent
Bryan Johnson, the 48-year-old longevity entrepreneur behind Blueprint, revealed he has autoimmune gastritis — a notoriously hard-to-diagnose condition where antibodies destroy the stomach's acid-prod
Northwestern Medicine reported in JAMA that double lung transplants enabled all 17 stage 4 lung cancer patients whose tumors hadn't spread to survive a full year, outperforming standard chemotherapy,
Prime Medicine won an arbitration ruling against Beam Therapeutics, clearing it to proceed with a clinical trial for a gene-editing drug targeting the rare liver disease alpha-1 antitrypsin deficiency
Two pharma developments are making headlines: the FDA approved Vera Therapeutics' $425,000-per-year kidney drug Trutakna for IgA nephropathy, while U.K. officials near a pricing deal with AstraZeneca
More than 80 years after its 1944 publication, Erwin Schrödinger's 'What Is Life?' continues to shape biophysics research with its physicist's framing of life, including the concept of 'negative entro
A WHO report projects global cancer cases will rise from 20.6 million annually to nearly 35 million by 2050, while warning that survival depends overwhelmingly on where a patient lives — with five-yea
Boston clinical psychologist Sarah Darghouth admits to using ChatGPT herself for parenting help while warning her therapy patients about AI's mental health risks, arguing the messy, uncertain nature o
Oxford researchers found that the narcolepsy drug pitolisant, which raises brain histamine levels, improved memory accuracy by 11% in a 60-person MRI trial — revealing histamine's surprisingly differe
A UCLA study finds that creatine, the popular muscle-building supplement, may help fight cancer by energizing dendritic cells that activate killer T cells, though the work is still limited to mice and
An 18-month Adelaide University trial found intermittent fasting matched calorie restriction for weight loss in adults with obesity, while feeling far less mentally burdensome — pointing to a more sus
The Trump administration's first-year science policy blitz — from mass firings of federal research staff to a Friday-night push to overhaul university reimbursement — was repeatedly blocked in federal
Two physicians argue the debate over licensing AI for clinical use misses licensure's core purpose: bearing personal responsibility for patient outcomes, which no algorithm, vendor, or health system c
Eli Lilly's once-daily oral weight-loss pill orforglipron outperformed oral semaglutide on both blood sugar control and weight loss in a 52-week Phase 3 trial of 1,698 adults with type 2 diabetes, but
Curated health stories, every morning. Free.
No spam. Unsubscribe anytime.